Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
NOV
NOV
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NOV News
NOV INC.: BARCLAYS LOWERS RATING TO UNDERWEIGHT FROM EQUAL-WEIGHT
2d ago
moomoo
NOV Inc. Q1 2026 Earnings Call Insights
Apr 28 2026
seekingalpha
NOV (NOV) Q1 2026 Earnings Call Transcript
Apr 28 2026
NASDAQ.COM
NOV Inc. Reports Decline in Q1 Earnings
Apr 28 2026
NASDAQ.COM
NOV Inc. Reports Q1 2026 Earnings with Revenue Decline Amid Middle East Disruptions
Apr 27 2026
Newsfilter
NOV Reports Q1 Earnings Miss with Share Buyback
Apr 27 2026
seekingalpha
NOV Reports Q1 Earnings Below Expectations
Apr 27 2026
Yahoo Finance
NOV Inc. Q1 Earnings Announcement Scheduled
Apr 26 2026
seekingalpha
NOV Set to Report Earnings; Market Anticipates Decline
Apr 26 2026
Yahoo Finance
NOV Expects First Quarter Results to Decline
Apr 15 2026
NASDAQ.COM
RBC Downgrades NOV to Sector Perform Amid Inflationary Pressures
Apr 14 2026
seekingalpha
Impact of Trump's Tariffs One Year Later
Apr 03 2026
CNBC
Iran War Triggers Heavy Selling in European Equity Markets
Mar 31 2026
CNBC
Novartis Plans $2 Billion Acquisition of Excellergy for Allergy Treatment
Mar 27 2026
CNBC
NOV Inc. Invests $200M to Double Subsea Pipe Capacity in Brazil
Mar 25 2026
seekingalpha
Merck Acquires Terns Pharmaceuticals for $6.7 Billion
Mar 25 2026
CNBC
Show More News
